In modern biotechnology and medicine antibodies are an integral part of almost all fields of application. Especially for the treatment of life-threatening diseases, such as cancer or autoimmune disorders, antibodies have been a consistent game-changer. However, antibody manufacturing is a challenging and very expensive process. This is reflected by high prices for antibody products and even higher costs for antibody therapeutics, limiting the impact on global health issues
Lumatix Biotech seeks to improve the availability and affordability of antibody products by disruptive technology innovation.
At Lumatix Biotech, we believe that constant innovation is crucial to overcoming current technological limitations and meeting future challenges of antibody manufacturing. Therefore, we are developing a light-controlled affinity matrix as a superior alternative to Protein A chromatography.
Learn more about how we develop cost-effective and innovative antibody isolation technology or feel free to get in touch with us!
Funding
